Testing which provides critical information in detection/management of allergic reactions.
Ended Awarded Last action
- Contract number
- HT009026FG1230012
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,733
Award facts
- Contract value 100% obligated
- $49,732.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $49,732.62 to Phadia US Inc.'s Immunodiagnostics Division on December 4, 2025, for allergy testing services that provide critical information in the detection and management of allergic reactions. The contract, which is set to be completed by September 30, 2026, will be performed in Portage, Michigan. As a subsidiary of Thermo Fisher Scientific specializing in advanced allergy and autoimmune diagnostic testing, Phadia US Inc. will deliver sophisticated immunological testing equipment, analyzers, and reagents to support military medical facilities' healthcare capabilities.
This BPA call represents a continuation of Phadia US Inc.'s established role as a primary vendor for the Defense Health Agency and other federal military medical agencies. The company maintains significant IDV vehicles with the Air Force valued at $13.8 million each for IMMUNOCAP system analyzers and related diagnostic equipment, underscoring its strategic importance in supporting military medical diagnostic capabilities. The current award reflects the open market procurement process, as no set-aside designation was utilized, and aligns with the company's consistent delivery of allergen-specific immunoglobulin E (IgE) antibody testing equipment and technical support services across the federal healthcare system.
Quick answers
Who was awarded contract HT009026FG1230012?
HT009026FG1230012 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on December 4, 2025.
How much is contract HT009026FG1230012 worth?
The government has obligated $49,733 on HT009026FG1230012.
Is contract HT009026FG1230012 an order under another contract?
Yes. HT009026FG1230012 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009026FG1230012 competed?
The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award